García NMC, García NLM, Cruz AY, García NLA, García NEM

Language: Spanish
References: 10
Page: 1-7
PDF size: 294.24 Kb.

ABSTRACT

The Wiscott Aldrich Syndrome is a well-defined primary immunodeficiency X- linked recessive disorder, the mutated gene encodes a cytoplasmatic protein in lymphocytes and megakaryocytes which is important in actin polymerization and cytoskeletal reorganization .The classic manifestations involve bleeding, infections and eczema. The first symptoms may appear at birth with petechial hemorrhage, diarrhea with blood, while infections and eczema are present during the first year of age, otitis media is an infection that occurs more frequently. From the immunological point of view it is characterized by low levels immunoglobulin M, immunoglobulin A and E are high, while immunoglobulin G may be normal together with thrombocytopenia. This disorder was diagnosed in a three- year- month infant who was admitted at intensive care unit for a long period of time. The patient died when he was two years old due to generalized infection.

REFERENCES

1. Blancas Galicia L, Escamilla Quiroz C, Yamazaki Nakashimada MA. Síndrome De Wiskott Aldrich; revisión actualizada. Rev Allergy Mexico 2011[citado 24 abr 2012]; 58(4.) Disponible en: http://www.artemisaenlinea.org.mx/articulo.php?id=6654&arte=a

2. Scott M, Leeper Laura R, Chung Chang Y. WASP interacting Protein Is Important for Actin Filament Elongation and Prompt Pseudopod Formation in Response to a Dynamic Chemoattractant Gradient. Mol Biol Cell.2006[citado 24 abr 2012]; 17 (10): 4564-4575. Disponible en: http://hmg.oxfordjournals.org/content/4/7/112

3. Bustamante JS, Bolsson Dupuis E, Jouanguy C. Picard: Novel primary immunodefieciencies revealed by the investigation of paediatric infectious deseases. Curr Opin Immunol. 2008; 20: 39-48.

4. Ochs HD, Thrasher AJ. The Wiskott Aldrich syndrome. J Allergy Clin Immunol. 2006[citado 24 abr 2013]; 117: 435-441.Disponible en: http://imunopediatria.org.br/download/wiskott.pdf

5. Fischer A. Human primary immunodeficiency diseases .Immunity. 2008; 28: 835- 846.

6. Abbas AK, Lichman AH, Pillai M. Congenital and acquired immnudeficiencies. En: Cellular and Molecular Immnology New York: Editorial Saunders Company. 2010. p.445-470.

7. Orangea JS, Stoneb KD, Turveyc K, Krzewskid SE . Biomedicine and Diseases: Review The Wiskott Aldrich syndrome. Cell Mol Life Sci. 2004[citado 24 abr 2013]; 61 Disponible en: http://zl.elsevier.es/es/revista/revista-alergia-mexico-336/articulo/sindrome-de-wiskott-aldrich-revision-actualizada-90090572

8. Notarangelo LD. Primary Immnodeficiencies. J Allergy Clin Immunol. 2010; 125:5182-5194.

9. Cuba. Ministerio de Salud Pública. Inmunoglobulina Humana. En: Formulario Nacional de medicamentos. La Habana: Editorial Ciencias Médicas; 2011.p.568-569.

10. Bustamante J, Boisson-Dupuis S, Jouanguy E, Picard C, Puel A, Abel L, et al. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr Opin Immunol. 2008; 20 (1): 39-48.